European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease

by NASDAQ Market News March 15, 2019

NASDAQ Market News
Click here to email author

Oncology Venture receives guarantees and undertakings for a proposed rights issue

Parental Pressure and Behavior May Put Teens at Risk for Substance Use and Abuse Say Experts from Caron Treatment Centers

Ads